Janssen Search
Search results
Janssen Human Microbiome Institute
Unlocking the Microbiome to Find Breakthrough Solutions That Promote Health Our focus is on accelerating the translation of the compelling science of the microbiome into breakthrough solutions that promote health. To achieve this, we are partnering with ...
Patience, Perseverance and Partnership
Patience, Perseverance and Partnership We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on developing solutions that prolong and improve patient lives. In this post, we’re proud to introduce you ...
Oncology Discovery & Early Development
Discovery and Early Development “We focus our deep expertise and understanding of disease biology and scientific innovation on specific tumor types with the greatest need for new treatment options.” Jeff Infante, M.D. Vice President, Oncology Early ...
Wim Parys, M.D.
Wim Parys, M.D., obtained his medical degree from the Katholieke Universiteit Leuven, Belgium. He was in private practice for nine years before joining the Janssen Research Foundation in Beerse, Belgium, where he held several R&D positions and ...
The Maturation of Digital Technologies
The Maturation of Digital Technologies Oct 13, 2016 In a Q&A with Clinical Leader magazine, Dmitri Talantov, M.D., R&D Operations Innovation Medical Leader, Janssen Research & Development, LLC, discussed the maturation of digital technologies ...
Peter M. DiBattiste, M.D.
Peter M. DiBattiste, M.D. is responsible for co-leading the Cardiovascular & Metabolism (CVM) Therapeutic Area at Janssen Research & Development, setting the strategy and leading the team in discovery and development of novel therapeutics for ...
Dan Baker, M.D.
Dan Baker, M.D. joined the Janssen Pharmaceutical Companies of Johnson & Johnson through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining ...
About Clinical Trials
Clinical Trials Clinical trials are conducted to evaluate the efficacy and safety of medicines and medical devices, and are essential steps in developing effective new medicines and treatments. Janssen companies sponsor and support clinical trials in more ...
Contact Us – Oncology
Contact Oncology at Janssen Apr 02, 2015 Thank you for your interest in learning more about our company. Interested in a potential collaboration with Janssen? Contact us with your idea. If you are a member of the media, and need to reach our Research & ...
Washington University Research Alliance
Research Alliance Marks Innovative Collaboration in Type 1 Diabetes Article Type: World Without Disease Accelerator Disease Interception Accelerator Cardiovascular & Metabolism Partnerships The Disease Interception Accelerator and Janssen ...